Argonaute RNA

About:

Argonaute RNA company research projects build on existing intellectual property.

Website: https://argonauterna.com/

Top Investors: Development Bank of Wales, Empirical Ventures, The Fink Family Office, Bristol Private Equity Club

Description:

Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. They show how their proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression.